Last week, Aqua Gen’s Quality controller Nina Santi described the company’s work on breeding a strain of salmon that could resist occurrences of IPN.
Small-scale trials have shown that 97.7 percent of salmon from a particular type of egg from Aqua Gen survive IPN infections, Santi said. Of these, only 10 percent were carriers of the disease afterwards.
The two other strains included in the trial fared less well. For one group, the survival rate was 47.5 percent, with 87 percent of the surviving fish still carrying the disease.
